Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
John A. Bates, PhD
Advertisement
Articles by John A. Bates, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
US Employer Health Care Costs Projected to Rise 9.5% in 2027
2
FDA Approves Nipocalimab-aahu as First Treatment for wAIHA
3
FDA Clears First Single-Biomarker Blood Test for Alzheimer
4
Lung Cancer Task Force Maps Research Roadmap to Close Survival Gap
5